Zoledronic Acid Dosing Interval for Metastatic Cancer

JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents / administration & dosage
  • Bone Neoplasms / drug therapy
  • Humans
  • Imidazoles / administration & dosage*
  • Neoplasms / drug therapy*

Substances

  • Bone Density Conservation Agents
  • Imidazoles